Skip to main content

Table 5 Association of sero-positivity to Chlamydia pneumoniae (CP), chlamydia heat shock protein (ch-hsp)60 with secondary fatal and non-fatal CVD events during follow up: Results of a multivariate analysis

From: Chlamydia pneumoniae, heat shock proteins 60 and risk of secondary cardiovascular events in patients with coronary heart disease under special consideration of diabetes: a prospective study

  

HR (95% CI)

  

Crude

Partially adjusted a

Fully adjusted b

CP (IgA)

    
 

Negative

1ref

1ref

1ref

 

Positive

1.60 (1.01–2.55)

1.60 (1.00–2.54)

1.46 (0.90–2.36)

CP (IgG)

    
 

Negative

1ref

1ref

1ref

 

Positive

1.46 (0.92–2.33)

1.44 (0.91–2.30)

1.39 (0.87–2.23)

ch-hsp60

    
 

Negative

1ref

1ref

1ref

 

Positive

1.12 (0.65–1.93)

1.09 (0.63–1.88)

1.01 (0.62–1.85)

  1. a = Adjusted for age and gender
  2. b = Adjusted for age, gender, HDL-cholesterol, smoking, alcohol consumption, school education, marital status, history of myocardial infarction, study centre
  3. (Test for interaction between diabetes and CP IgA (p = 0.60), CP IgG (p = 0.86) and ch-hsp60 (p = 0.46))